Study #2015-0165
Early Non-Invasive Ventilation in Patients with Hypoxemic Respiratory Failure and Malignancies: A Prospective Randomized Controlled Trial
MD Anderson Study Status
Enrolling
Treatment Agent
Methylprednisolone
Description
This randomized clinical trial studies how well non-invasive ventilation works in reducing the need for intubation, or placement of a tube in the windpipe, in patients with cancer and respiratory failure. Respiratory failure is a condition in which not enough oxygen passes from the lungs to the blood, and is a common cause of admission to the emergency room in patients with hematological and solid tumor patients. Non-invasive positive pressure ventilation (NIPPV) is a method of delivering oxygen using a mask. It is not yet known whether NIPPV is better at improving the amount of oxygen in the blood, reducing shortness of breath, and the need for intubation than standard high flow oxygen (a tube with 2 prongs placed in the nostrils) in patients with cancer and respiratory failure.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Study phase:
Not applicable
Physician name:
Nisha Rathi
Department:
Critical Care
For general questions about clinical trials:
1-833-642-1954
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.